Brian C. Hsia

Brian C. Hsia

Auto-generated profile, based on publicly available information

Brian C. Hsia

Leon H. Charney Division of Cardiology NYU Langone Health New York New York USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
BHBrian C. Hsia
Brian C. Hsia
ASAnjani K. Singh
Anjani K. Singh
ONObumneme Njeze
Obumneme Njeze
ECEmine Cosar
Emine Cosar
WMWenzhu B. Mowrey
Wenzhu B. Mowrey
SJSunit Jariwala
Sunit Jariwala

2 June 2020 in Respiratory Care
Verified
Journal Article
Closed access
PDF file
BHBrian C Hsia
Brian C Hsia
SWSammy Wu
Sammy Wu
WMWenzhu B Mowrey
Wenzhu B Mowrey
SJSunit Jariwala
Sunit Jariwala
BACKGROUND: We sought to longitudinally assess the efficacy of the patient-facing ASTHMAXcel mobile application in improving asthma knowledge and outcomes in adults with asthma. METHODS: ASTHMAXcel is a novel smartphone application consistent with the National Asthma Education and Prevention Program, Global Initiative for Asthma, and British Thoracic Society/Scottish Intercollegiate Guidelines Network guidelines. The intervention was provided for 1-time use at baseline only. The Asthma Knowledge Questionnaire (AKQ), the Asthma Control Test (ACT), and the mini-Asthma Quality of Life Questionnaire (mini-AQLQ) were administered at baseline and at 2, 4, and 6 months thereafter. Rates of asthma-related emergency department visits, hospitalizations, and prednisone use were also evaluated. RESULTS: ACT scores increased significantly at 2, 4, and 6 months (mean scores: 15.1 vs 16.9, P = .038; 15.1 vs 17.2, P = .02; 15.1 vs 17.9, P = .003) after baseline. There were significant increases in AKQ scores at 4 and 6 months (11.7 vs 12.6, P = .02; 11.7 vs 13.1, P = .005) and in mini-AQLQ scores at 6 months (55.5 vs 64.2, P = .02). There were significant decreases in asthma-related emergency department visits at 6 months (0.6 vs 0, P < .001) and in hospitalizations at 4 and 6 months (0.3 vs 0.1, P = .02; 0.3 vs 0, P = .002). Prednisone use decreased at 4 and 6 months (1.2 vs 0.6, P = .01; 1.2 vs 0.3, P < .001). CONCLUSIONS: ASTHMAXcel contributes to improved asthma knowledge and outcomes and to decreased health care utilization. ASTHMAXcel is an inexpensive, scalable aid for out-patient asthma management.

19 February 2020 in Journal of Asthma
Verified
Journal Article
Closed access
BHBrian Hsia
Brian Hsia
WMWenzhu Mowrey
Wenzhu Mowrey
TKTaha Keskin
Taha Keskin
SWSammy Wu
Sammy Wu
RARohit Aita
Rohit Aita
SJSunit Jariwala
Sunit Jariwala
Objective: We sought to compare the impact of ASTHMAXcel, a novel, guideline-based, patient-facing mobile app to human-delivered asthma education. Methods: We conducted a focus group with asthma patients in the Bronx to identify desired mobile app features. ASTHMAXcel was designed based on patient feedback and consistent with NAEPP, BTS/SIGN, and GINA guidelines. The app was reviewed by internists, allergist/immunologists, and pulmonologists specializing in asthma treatment, asthma educators, and a behavioral scientist, and iteratively refined. The refined version of ASTHMAXcel was administered once via tablet at our outpatient Montefiore Asthma Center (MAC). Asthma knowledge was measured through the Asthma Knowledge Questionnaire (AKQ) pre and post-intervention. We also recorded process outcomes including completion time and patient satisfaction. In parallel, human-delivered education was delivered once at MAC. These outcomes were similarly collected. Results: 60 patients were enrolled with 30 in the ASTHMAXcel and 30 in the human-educator group. Mean AKQ in the ASTHMAXcel group vs human-educator group pre-intervention was 9.9 vs 10.5, p = 0.27. Mean AKQ post-intervention in the ASTHMAXcel group vs human-educator group was 12.3 vs 14.4, p = 0.0002. The mean AKQ improvement for both groups were 2.4 vs 3.9, p = 0.007. Patients were highly satisfied in the ASTHMAXcel group scoring on average 27.9 out of 30 maximum points on the satisfaction survey. There was no difference in satisfaction scores or completion times (minutes) of either intervention. Conclusion: ASTHMAXcel was associated with an increase in AKQ, but the human-educator group experienced a greater improvement. ASTHMAXcel demonstrated no differences in process outcomes vs human-delivered education.

16 June 2023 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
BHBrian C. Hsia
Brian C. Hsia
ALAshton Lai
Ashton Lai
SSSupreet Singh
Supreet Singh
RSRajeev Samtani
Rajeev Samtani
SBSolomon Bienstock
Solomon Bienstock
MGMartin E. Goldman
Martin E. Goldman

11 July 2020 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
BHBrian C Hsia
Brian C Hsia
NGNicolas Greige
Nicolas Greige
JQJose A Quiroz
Jose A Quiroz
AKAhmed S Khokhar
Ahmed S Khokhar
JDJohanna Daily
Johanna Daily
AKAndrew Krumerman
Andrew Krumerman

1 December 2020 in Heart Rhythm
Verified
Journal Article
Closed access
BHBrian C. Hsia
Brian C. Hsia
NGNicolas Greige
Nicolas Greige
SPShreyans K. Patel
Shreyans K. Patel
RCRachel M. Clark
Rachel M. Clark
KFKevin J. Ferrick
Kevin J. Ferrick
AKAndrew Krumerman
Andrew Krumerman